Suppr超能文献

高级别肢体软组织肉瘤新辅助化疗后的组织学改变:临床病理相关性

Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlation.

作者信息

Lucas David R, Kshirsagar Malti P, Biermann J Sybil, Hamre Merlin R, Thomas Dafydd G, Schuetze Scott M, Baker Laurence H

机构信息

Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109-0054, USA.

出版信息

Oncologist. 2008 Apr;13(4):451-8. doi: 10.1634/theoncologist.2007-0220.

Abstract

Histologic response to chemotherapy is generally regarded as an independent prognostic variable in bone sarcomas, both osteosarcoma and Ewing's sarcoma. In soft tissue sarcomas, however, descriptions of histologic alterations from chemotherapy and correlative outcome studies are much more limited. Herein we report clinicopathological findings from a homogeneously treated group of 31 patients with tumor stage T2 grade 3 extremity soft tissue sarcomas treated with the same neoadjuvant chemotherapy followed by surgical excision, treated by the same medical oncologist and orthopedic surgeon. Histologic response to therapy was evaluated by multiple parameters using a semiquantitative grading system. Based upon the percentage of post-treatment viable tumor, tumors were arbitrarily categorized similarly to Huvos score as showing excellent (< or =5% viability), moderate (6%-49% viability), or poor (> or =50% viability) responses. Nineteen percent had excellent, 10% had moderate, and 71% had poor responses. These histologic response groups did not correlate with overall or event-free survival. For example, of the 22 patients showing a "poor" response, 13 were cured. Similarly, other histologic parameters, including percentages of necrosis, fibrosis/hyalinization, and cellular degeneration, did not correlate with outcome. Chemotherapy induces profound tissue alterations in soft tissue sarcomas. However, histologic alteration by itself may not be a reliable prognostic variable. Correlation of all data from clinical, imaging, and pathological observations by a multidisciplinary tumor board should have greater prognostic value than histology alone. Finally, although the histologic grading system used in this study could not be validated, the criteria we employed are simple and reproducible and take into account the major histologic patterns seen after therapy, and would be amenable for use in future studies.

摘要

化疗的组织学反应通常被视为骨肉瘤(包括骨肉瘤和尤文肉瘤)的一个独立预后变量。然而,在软组织肉瘤中,关于化疗引起的组织学改变的描述以及相关的预后研究要有限得多。在此,我们报告了一组31例肿瘤分期为T2 3级肢体软组织肉瘤患者的临床病理结果,这些患者接受了相同的新辅助化疗,随后进行手术切除,由同一位医学肿瘤学家和骨科医生治疗。使用半定量分级系统通过多个参数评估对治疗的组织学反应。根据治疗后存活肿瘤的百分比,肿瘤被随意分类,类似于胡沃斯评分,分为显示良好(存活<或=5%)、中等(存活6%-49%)或差(存活>或=50%)反应。19%的患者反应良好,10%的患者反应中等,71%的患者反应差。这些组织学反应组与总生存期或无事件生存期无关。例如,在22例显示“差”反应的患者中,13例治愈。同样,其他组织学参数,包括坏死、纤维化/透明变性和细胞变性的百分比,与预后也无关。化疗会在软组织肉瘤中引起深刻的组织改变。然而,组织学改变本身可能不是一个可靠的预后变量。多学科肿瘤委员会对临床、影像学和病理学观察的所有数据进行关联,可能比单纯的组织学具有更大的预后价值。最后,尽管本研究中使用的组织学分级系统无法得到验证,但我们采用的标准简单且可重复,考虑到了治疗后出现的主要组织学模式,适用于未来的研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验